000 | 00983 a2200289 4500 | ||
---|---|---|---|
005 | 20250513150328.0 | ||
264 | 0 | _c19980908 | |
008 | 199809s 0 0 fre d | ||
022 | _a1262-3636 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBlickle, J F | |
245 | 0 | 0 |
_a[Hypoglycemic sulfamides: new pharmacologic data and practical implications]. _h[electronic resource] |
260 |
_bDiabetes & metabolism _cJun 1998 |
||
300 |
_a276-80 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperglycemia _xdrug therapy |
650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
650 | 0 | 4 |
_aInsulin _xtherapeutic use |
650 | 0 | 4 | _aPractice Patterns, Physicians' |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSulfonylurea Compounds _xadverse effects |
700 | 1 | _aBrogard, J M | |
773 | 0 |
_tDiabetes & metabolism _gvol. 24 _gno. 3 _gp. 276-80 |
|
999 |
_c9655735 _d9655735 |